Daily Reporter

Refine search

Date

Any time

This month

This year

Before this year

14 results for ""

Sort by

Therapy

Switching from intravenous to oral or subcutaneous cancer treatment: a sustainable approach?

Despite alternative modes of administering anticancer medicines have reinforced the idea that at-home cancer care may be sometimes feasible as well as preferred by patients, there are concerns about costs of and accessibility to these new opportunities.

11 Dec 2020

Cancer in Special Situations/ Populations

Is COVID-19 turning back the clock for patient empowerment?

After years of progress in empowering patients with cancer to play a more active role in their care, the COVID-19 pandemic is leaving many feeling anxious with little control over if, when or how they will receive a diagnosis or treatment.

20 Oct 2020

Cancer in Special Situations/ Populations

Patients with cancer and research: will COVID-19 further damage opportunities to join experimental trials?

Patients are missing out on potentially lifesaving clinical trials, but the pandemic era could be the trigger for a much-needed change in practice, says Dr Bettina Ryll, Founder of the Melanoma Patient Network Europe.

20 Oct 2020

Cancer in Special Situations/ Populations

How to make the right therapeutic choice for cancer patients at a time of crisis

According to Prof. Alberto Sobrero the most effective anticancer treatment is not always the right choice, and safely reducing treatment doses and duration is worthwhile when considered in keeping with patient values.

20 Oct 2020